FRANKFURT (Reuters) - Merck KGaA would not bid for ImClone Systems Inc on its own, but may consider taking part in a potential approach for the U.S. drugmaker, Merck’s Chief Executive Karl-Ludwig Kley said.
FRANKFURT (Reuters) - Merck KGaA would not bid for ImClone Systems Inc on its own, but may consider taking part in a potential approach for the U.S. drugmaker, Merck’s Chief Executive Karl-Ludwig Kley said.
